AIMS & SCOPE – Current Vascular Pharmacology

Aims & Scope:

Current Vascular Pharmacology publishes clinical and research-based reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

 

 

For more details, please visit: https://benthamscience.com/journals/current-vascular-pharmacology/aims-scope/#top

Upcoming Thematic Issue – Vascular Protection of Herbal Medicine:Roles and Mechanisms

http://benthamscience.com/journals/current-vascular-pharmacology/

New Issue ::: Current Vascular Pharmacology

Current Vascular Pharmacology publishes clinical and research-based reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

Articles from the journal Current Vascular Pharmacology, 14 Issue 3:

 

• Non-Vitamin K Oral Anticoagulants (NOACs) A Review of Clinical Management and Laboratory Issues
• Nitric Oxide is a Central Common Metabolite in Vascular Dysfunction Associated with Diseases of Human Pregnancy
• The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease
• Nitric Oxide as a Marker for Levo-Thyroxine Therapy in Subclinical Hypothyroid Patients
• Editorial: Cardiovascular Disease Mortality Rates are Plateauing in Certain Age Groups and Regions. Can we Keep them Declining?
• Imiquimod Increases Cutaneous VEGF Expression in Imiquimod-induced Psoriatic Mouse Model
• Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders
• Low Osteopontin N-Terminal Fragment and Carotid Plaque Stability Associated with Statin or Antiplatelet Therapy
• Diabetes Mellitus, Hypertension and Hypercholesterolemia in Relation to the 10-Year ACS Prognosis; the GREECS Study
• Editorial: Statins and Tissue Plasminogen Activator for Stroke: A Beneficial Combination?
• Editorial: Cocaine and Cerebral Small Vessel: Is it a Negative Factor for Intravenous Thrombolysis?

For details on the articles, please visit this link :: http://bit.ly/1Vdf9wg

 

 

New Issue ::: Current Vascular Pharmacology

Current Vascular Pharmacology publishes clinical and research-based reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

Articles from the journal in Current Vascular Pharmacology, Volume 14 Issue 2:

 

• Editorial (Thematic Issue: Endothelium: A Target for Therapeutic Intervention)
• Purinergic Signalling and Endothelium
• Valve Endothelial Cells – Not Just Any Old Endothelial Cells
• The Emerging Role of Arginase in Endothelial Dysfunction in Diabetes
• Is Erectile Dysfunction an Example of Abnormal Endothelial Function?
• Adiponectin: An Endothelium-Derived Vasoprotective Factor?
• Endothelial Lessons
• Regulation of Vascular Endothelium Inflammatory Signalling by Shear Stress
• Vascular Endothelium and Hypovolemic Shock
• Protective Role of Diabetes Mellitus on Abdominal Aortic Aneurysm Pathogenesis: Myth or Reality?
• The Current Role of Liraglutide in the Pharmacotherapy of Obesity
• Editorial: Vascular Calcification, Cardiovascular Risk and microRNAs
• miR-135a Suppresses Calcification in Senescent VSMCs by Regulating KLF4/STAT3 Pathway

For details on the articles, please visit this link :: http://bit.ly/1YPvYfo